Drug approval challenges in the age of personalized cancer treatment

Author： Schilsky Richard L  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.8, Iss.6, 2011-11, pp. : 633-640

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized Treatment of Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 1, 2012-01 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

Pharmacogenomic biomarkers for personalized cancer treatment

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 2, 2015-02 ,pp. : 201-217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Without Therapeutic Drug Monitoring, There Is No Personalized Cancer Care

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 3, 2013-03 ,pp. : 228-230

John Wiley & Sons Inc

Access to resources Recommend Favorite

Challenges and Exciting New Opportunities to Advance Personalized Treatment for Alcohol Use Disorder

By  

ALCOHOLISM (ELECTRONIC), Vol. 39, Iss. 4, 2015-04 ,pp. : 587-588

John Wiley & Sons Inc

Access to resources Recommend Favorite

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 3, 2013-03 ,pp. : 252-259

John Wiley & Sons Inc

Access to resources Recommend Favorite